Meng Lingfeng, Hou Huimin, Zhang Peng, Gu Yinjun, Shi Benkang, Li Yan, Wang Qingwei, Zhang Yifei, Ren Lijuan, Chen Qi, Yuan Zhen, Guo Fan, Li Dianyou, Ma Yunfu, Dong Sheng, Liu Zhijun, Shang Aijia, Li Bo, Xu Wei, Lv Jianwei, Zhang Yaoguang
Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Department of Urology, Beijing Hospital Continence Center, Beijing, China.
Front Med (Lausanne). 2023 Mar 13;10:977433. doi: 10.3389/fmed.2023.977433. eCollection 2023.
Sacral neuromodulation is an effective, minimally invasive treatment for refractory lower urinary tract dysfunction. However, regular postoperative programming is crucial for the maintenance of the curative effects of electronic sacral stimulator devices. The outbreak of coronavirus disease 2019 (COVID-19) limited the ability of practitioners to perform traditional face-to-face programming of these stimulators. Therefore, this study aimed to evaluate the application of remote programming technology for sacral neuromodulation during the COVID-19 pandemic in China.
We retrospectively collected data including baseline and programming information of all patients with lower urinary tract dysfunction who underwent sacral neuromodulation remote programming in China after the outbreak of COVID-19 (i.e., December 2019). The patients also completed a self-designed telephone questionnaire on the subject.
A total of 51 patients from 16 centers were included. They underwent 180 total remote programming visits, and 118, 2, 25, and 54 voltage, current, pulse width, and frequency adjustments, respectively, were performed. Additionally, remote switching on and off was performed 8 times; impedance test, 54 times; and stimulation contact replacement, 25 times. The demand for remote programming was the highest during the first 6 months of sacral neuromodulation (average, 2.39 times per person). In total, 36 out of the 51 patients completed the questionnaire survey. Of these, all indicated that they chose remote programming to minimize unnecessary travel because they had been affected by COVID-19. The questionnaire also showed that remote programming could reduce the number of patient visits to the hospital, save time, reduce financial costs, and would be easy for patients to master. All surveyed patients indicated that they were satisfied with remote programming and were willing to recommend it to other patients.
Remote programming for sacral neuromodulation is feasible, effective, safe, and highly recommended by patients with refractory lower urinary tract dysfunction. Remote programming technology has great development and application potential in the post-pandemic era.
骶神经调节是治疗难治性下尿路功能障碍的一种有效、微创的治疗方法。然而,术后定期程控对于维持电子骶神经刺激器设备的疗效至关重要。2019年冠状病毒病(COVID-19)的爆发限制了从业者对这些刺激器进行传统面对面程控的能力。因此,本研究旨在评估在中国COVID-19大流行期间骶神经调节远程程控技术的应用情况。
我们回顾性收集了COVID-19爆发后(即2019年12月)在中国接受骶神经调节远程程控的所有下尿路功能障碍患者的基线和程控信息。患者还完成了一份关于该主题的自行设计的电话调查问卷。
共纳入来自16个中心的51例患者。他们总共进行了180次远程程控就诊,分别进行了118次、2次、25次和54次电压、电流、脉宽和频率调整。此外,进行了8次远程开关操作;54次阻抗测试;以及25次刺激触点更换。骶神经调节术后前6个月对远程程控的需求最高(平均每人2.39次)。51例患者中共有36例完成了问卷调查。其中,所有患者均表示他们选择远程程控是为了尽量减少不必要的出行,因为他们受到了COVID-19的影响。问卷还显示,远程程控可以减少患者的医院就诊次数、节省时间、降低经济成本,并且患者易于掌握。所有接受调查的患者均表示他们对远程程控满意,并愿意向其他患者推荐。
骶神经调节远程程控是可行、有效、安全的,并且受到难治性下尿路功能障碍患者的高度推荐。远程程控技术在大流行后时代具有巨大的发展和应用潜力。